EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis

Layla A Abushamat, Pir Ahmad Shah, Robert H Eckel, Stephen A Harrison, Diana Barb

Clinical Gastroenterology and Hepatology · 2024-08 · 22 (8) · 1565-1574

DOI: 10.1016/j.cgh.2024.01.032 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024-08. Verfasst von Layla A Abushamat und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, Texas. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit wurde bisher 101-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide-1 Receptor AgonistsHumansFatty LiverDiabetes Mellitus, Type 2Obesity

Stichwörter der Autor:innen

CirrhosisGLP-1Metabolic Dysfunction-Associated Steatotic Liver DiseaseSteatosis

Substanzen

Glucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Gastroenterology and Hepatology, Creighton University, Phoenix, Arizona.
  • Division of Endocrinology, Metabolism & Diabetes, Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Pinnacle Clinical Research, San Antonio, Texas.
  • Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, Florida. Electronic address: Diana.Barb@medicine.ufl.edu.

Zitieren

APA

Abushamat, L. A., Shah, P. A., Eckel, R. H., Harrison, S. A., & Barb, D. (2024). The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis. Clinical Gastroenterology and Hepatology, 22(8), 1565-1574. https://doi.org/10.1016/j.cgh.2024.01.032

Vancouver

Abushamat LA, Shah PA, Eckel RH, Harrison SA, Barb D. The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis. Clinical Gastroenterology and Hepatology. 2024;22(8):1565-1574. doi:10.1016/j.cgh.2024.01.032

BibTeX
@article{Abushamat2024,
  author = {Abushamat, Layla A and Shah, Pir Ahmad and Eckel, Robert H and Harrison, Stephen A and Barb, Diana},
  title = {The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2024},
  volume = {22},
  number = {8},
  pages = {1565--1574},
  doi = {10.1016/j.cgh.2024.01.032}
}
Kostenlos starten →